{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T06:40:38Z","timestamp":1764225638137},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00063-021-00781-9","type":"journal-article","created":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T15:06:10Z","timestamp":1613228770000},"page":"129-134","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Die h\u00e4mophagozytische Lymphohistiozytose bei kritisch kranken Patienten","Hemophagocytic lymphohistiocytosis in critically ill patients"],"prefix":"10.1007","volume":"116","author":[{"given":"D. A.","family":"Eichenauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Lachmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"La Ros\u00e9e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,12]]},"reference":[{"key":"781_CR1","doi-asserted-by":"publisher","first-page":"e630","DOI":"10.1016\/S2352-3026(19)30156-5","volume":"6","author":"A Ahmed","year":"2019","unstructured":"Ahmed\u00a0A, Merrill\u00a0SA, Alsawah\u00a0F et al (2019) Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial. Lancet Haematol 6:e630\u2013e637. https:\/\/doi.org\/10.1016\/S2352-3026(19)30156-5","journal-title":"Lancet Haematol"},{"key":"781_CR2","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s00432-020-03139-4","volume":"146","author":"S Birndt","year":"2020","unstructured":"Birndt\u00a0S, Schenk\u00a0T, Heinevetter\u00a0B et\u00a0al (2020) Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137\u00a0cases of a\u00a0nationwide German registry. J\u00a0Cancer Res Clin Oncol 146:1065\u20131077. https:\/\/doi.org\/10.1007\/s00432-020-03139-4","journal-title":"J Cancer Res Clin Oncol"},{"key":"781_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/bjh.14147","volume":"174","author":"E Brisse","year":"2016","unstructured":"Brisse\u00a0E, Wouters\u00a0CH, Matthys\u00a0P (2016) Advances in the pathogenesis of primary and secondary haemophagocytic lymphohistiocytosis: differences and similarities. Br J Haematol 174:203\u2013217. https:\/\/doi.org\/10.1111\/bjh.14147","journal-title":"Br J Haematol"},{"key":"781_CR4","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/ajcp\/aqw076","volume":"145","author":"F Debaugnies","year":"2016","unstructured":"Debaugnies\u00a0F, Mahadeb\u00a0B, Ferster\u00a0A et al (2016) Performances of the H\u2011score for diagnosis of hemophagocytic lymphohistiocytosis in adult and pediatric patients. Am J Clin Pathol 145:862\u2013870. https:\/\/doi.org\/10.1093\/ajcp\/aqw076","journal-title":"Am J Clin Pathol"},{"key":"781_CR5","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/art.38690","volume":"66","author":"L Fardet","year":"2014","unstructured":"Fardet\u00a0L, Galicier\u00a0L, Lambotte\u00a0O et\u00a0al (2014) Development and validation of the HScore, a\u00a0score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol 66:2613\u20132620. https:\/\/doi.org\/10.1002\/art.38690","journal-title":"Arthritis Rheumatol"},{"key":"781_CR6","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1093\/cid\/ciy1025","volume":"69","author":"JA Fishman","year":"2019","unstructured":"Fishman\u00a0JA, Hogan\u00a0JI, Maus\u00a0MV (2019) Inflammatory and infectious syndromes associated with cancer immunotherapies. Clin Infect Dis 69:909\u2013920. https:\/\/doi.org\/10.1093\/cid\/ciy1025","journal-title":"Clin Infect Dis"},{"key":"781_CR7","doi-asserted-by":"publisher","first-page":"887","DOI":"10.21037\/atm-20-3127","volume":"8","author":"JB Gabr","year":"2020","unstructured":"Gabr\u00a0JB, Liu\u00a0E, Mian\u00a0S et al (2020) Successful treatment of secondary macrophage activation syndrome with emapalumab in a\u00a0patient with newly diagnosed adult-onset Still\u2019s disease: case report and review of the literature. Ann Transl Med 8:887. https:\/\/doi.org\/10.21037\/atm-20-3127","journal-title":"Ann Transl Med"},{"key":"781_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10875-017-0377-7","volume":"37","author":"C Greil","year":"2017","unstructured":"Greil\u00a0C, Roether\u00a0F, La Ros\u00e9e\u00a0P et al (2017) Rescue of cytokine storm due to HLH by hemoadsorption in a\u00a0CTLA4-deficient patient. J\u00a0Clin Immunol 37:273\u2013276. https:\/\/doi.org\/10.1007\/s10875-017-0377-7","journal-title":"J Clin Immunol"},{"key":"781_CR9","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/S0140-6736(06)68232-9","volume":"367","author":"JI Henter","year":"2006","unstructured":"Henter\u00a0JI, Chow\u00a0CB, Leung\u00a0CW, Lau\u00a0YL (2006) Cytotoxic therapy for severe avian influenza A (H5N1) infection. Lancet 367:870\u2013873. https:\/\/doi.org\/10.1016\/S0140-6736(06)68232-9","journal-title":"Lancet"},{"key":"781_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter\u00a0JI, Horne\u00a0A, Arico\u00a0M et al (2007) HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48:124\u2013131. https:\/\/doi.org\/10.1002\/pbc.21039","journal-title":"Pediatr Blood Cancer"},{"key":"781_CR11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436","author":"P Horby","year":"2020","unstructured":"Horby\u00a0P, Lim\u00a0WS, Emberson\u00a0JR et al (2020) Dexamethasone in hospitalized patients with Covid-19\u2014preliminary report. N\u00a0Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2021436","journal-title":"N Engl J Med"},{"key":"781_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5492\/wjccm.v7.i6.73","volume":"7","author":"S Kapoor","year":"2018","unstructured":"Kapoor\u00a0S, Morgan\u00a0CK, Siddique\u00a0MA, Guntupalli\u00a0KK (2018) Intensive care unit complications and outcomes of adult patients with hemophagocytic lymphohistiocytosis: a retrospective study of 16\u00a0cases. World J Crit Care Med 7:73\u201383. https:\/\/doi.org\/10.5492\/wjccm.v7.i6.73","journal-title":"World J Crit Care Med"},{"key":"781_CR13","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s13054-020-02941-3","volume":"24","author":"C Knaak","year":"2020","unstructured":"Knaak\u00a0C, Nyvlt\u00a0P, Schuster\u00a0FS et al (2020) Hemophagocytic lymphohistiocytosis in critically ill patients: diagnostic reliability of HLH-2004 criteria and HScore. Crit Care 24:244. https:\/\/doi.org\/10.1186\/s13054-020-02941-3","journal-title":"Crit Care"},{"key":"781_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000004581","author":"C Knaak","year":"2020","unstructured":"Knaak\u00a0C, Schuster\u00a0FS, Nyvlt\u00a0P et\u00a0al (2020) Treatment and mortality of hemophagocytic lymphohistiocytosis in adult critically ill patients: a systematic review with pooled analysis. Crit Care Med. https:\/\/doi.org\/10.1097\/CCM.0000000000004581","journal-title":"Crit Care Med"},{"key":"781_CR15","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1097\/SHK.0000000000001454","volume":"53","author":"C Knaak","year":"2020","unstructured":"Knaak\u00a0C, Schuster\u00a0FS, Spies\u00a0C et\u00a0al (2020) Hemophagocytic lymphohistiocytosis in critically ill patients. Shock 53:701\u2013709. https:\/\/doi.org\/10.1097\/SHK.0000000000001454","journal-title":"Shock"},{"key":"781_CR16","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1182\/blood.2018894618","volume":"133","author":"P La Ros\u00e9e","year":"2019","unstructured":"La Ros\u00e9e\u00a0P, Horne\u00a0A, Hines\u00a0M et\u00a0al (2019) Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood 133:2465\u20132477. https:\/\/doi.org\/10.1182\/blood.2018894618","journal-title":"Blood"},{"key":"781_CR17","first-page":"20","volume":"28","author":"P La Ros\u00e9e","year":"2020","unstructured":"La Ros\u00e9e\u00a0P, Bremer\u00a0HC, La Ros\u00e9e\u00a0F et al (2020) Interdisciplinary COVID board for patients with SARS-CoV-2-triggered hyperferritinemic inflammation. Med Klin Intensivmed Notfmed 28:20\u2013750","journal-title":"Med Klin Intensivmed Notfmed"},{"key":"781_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/SHK.0000000000001048","volume":"50","author":"G Lachmann","year":"2018","unstructured":"Lachmann\u00a0G, Spies\u00a0C, Schenk\u00a0T et\u00a0al (2018) Hemophagocytic lymphohistiocytosis: potentially underdiagnosed in intensive care units. Shock 50:149\u2013155. https:\/\/doi.org\/10.1097\/SHK.0000000000001048","journal-title":"Shock"},{"key":"781_CR19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/CCM.0000000000004131","volume":"48","author":"G Lachmann","year":"2020","unstructured":"Lachmann\u00a0G, Knaak\u00a0C, Vorderwulbecke\u00a0G et\u00a0al (2020) Hyperferritinemia in critically ill patients. Crit Care Med 48:459\u2013465. https:\/\/doi.org\/10.1097\/CCM.0000000000004131","journal-title":"Crit Care Med"},{"key":"781_CR20","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/bjh.13462","volume":"170","author":"K Lehmberg","year":"2015","unstructured":"Lehmberg\u00a0K, Sprekels\u00a0B, Nichols\u00a0KE et al (2015) Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents. Br J Haematol 170:539\u2013549. https:\/\/doi.org\/10.1111\/bjh.13462","journal-title":"Br J Haematol"},{"key":"781_CR21","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMoa1911326","volume":"382","author":"F Locatelli","year":"2020","unstructured":"Locatelli\u00a0F, Jordan\u00a0MB, Allen\u00a0C et\u00a0al (2020) Emapalumab in children with primary hemophagocytic lymphohistiocytosis. N\u00a0Engl J Med 382:1811\u20131822. https:\/\/doi.org\/10.1056\/NEJMoa1911326","journal-title":"N Engl J Med"},{"key":"781_CR22","doi-asserted-by":"publisher","DOI":"10.1177\/0885066619837139","author":"NK Meena","year":"2019","unstructured":"Meena\u00a0NK, Sinokrot\u00a0O, Duggal\u00a0A et\u00a0al (2019) The performance of diagnostic criteria for hemophagocytic lymphohistiocytosis in critically ill patients. J\u00a0Intensive Care Med. https:\/\/doi.org\/10.1177\/0885066619837139","journal-title":"J Intensive Care Med"},{"key":"781_CR23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/annrheumdis-2015-208982","volume":"75","author":"A Ravelli","year":"2016","unstructured":"Ravelli\u00a0A et\u00a0al (2016) 2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European league against rheumatism\/American college of rheumatology\/paediatric rheumatology international trials organisation collaborative initiative. Ann Rheum Dis 75:481\u2013489","journal-title":"Ann Rheum Dis"},{"key":"781_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","volume":"44","author":"B Shakoory","year":"2016","unstructured":"Shakoory\u00a0B, Carcillo\u00a0JA, Chatham\u00a0WW et al (2016) Interleukin\u20111 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a\u00a0prior phase III trial. Crit Care Med 44:275\u2013281. https:\/\/doi.org\/10.1097\/CCM.0000000000001402","journal-title":"Crit Care Med"},{"key":"781_CR25","doi-asserted-by":"publisher","first-page":"59977","DOI":"10.18632\/oncotarget.19230","volume":"8","author":"H Wang","year":"2017","unstructured":"Wang\u00a0H, Xiong\u00a0L, Tang\u00a0W et al (2017) A systematic review of malignancy-associated hemophagocytic lymphohistiocytosis that needs more attentions. Oncotarget 8:59977\u201359985. https:\/\/doi.org\/10.18632\/oncotarget.19230","journal-title":"Oncotarget"},{"key":"781_CR26","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1182\/blood-2015-05-644914","volume":"126","author":"Y Wang","year":"2015","unstructured":"Wang\u00a0Y, Huang\u00a0W, Hu\u00a0L et\u00a0al (2015) Multicenter study of combination DEP regimen as a\u00a0salvage therapy for adult refractory hemophagocytic lymphohistiocytosis. Blood 126:2186\u20132192. https:\/\/doi.org\/10.1182\/blood-2015-05-644914","journal-title":"Blood"},{"key":"781_CR27","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.253781","author":"Q Zhang","year":"2020","unstructured":"Zhang\u00a0Q, Wei\u00a0A, Ma\u00a0H\u2011H et al (2020) A pilot study of ruxolitinib as a\u00a0front-line therapy for 12\u00a0children with secondary hemophagocytic lymphohistiocytosis. Haematologica. https:\/\/doi.org\/10.3324\/haematol.2020.253781","journal-title":"Haematologica"},{"key":"781_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16861","author":"Y Zhao","year":"2020","unstructured":"Zhao\u00a0Y, Li\u00a0Z, Zhang\u00a0L et al (2020) L\u2011DEP regimen salvage therapy for paediatric patients with refractory Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis. Br J Haematol. https:\/\/doi.org\/10.1111\/bjh.16861","journal-title":"Br J Haematol"},{"key":"781_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2147\/TCRM.S155488","volume":"14","author":"S Zhou","year":"2018","unstructured":"Zhou\u00a0S, Qiao\u00a0J, Bai\u00a0J et al (2018) Biological therapy of traditional therapy-resistant adult-onset still\u2019s disease: an evidence-based review. Ther Clin Risk Manag 14:167\u2013171. https:\/\/doi.org\/10.2147\/TCRM.S155488","journal-title":"Ther Clin Risk Manag"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-021-00781-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00063-021-00781-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-021-00781-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T09:26:48Z","timestamp":1614936408000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00063-021-00781-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,12]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["781"],"URL":"https:\/\/doi.org\/10.1007\/s00063-021-00781-9","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"type":"print","value":"2193-6218"},{"type":"electronic","value":"2193-6226"}],"subject":[],"published":{"date-parts":[[2021,2,12]]},"assertion":[{"value":"1 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"D.\u00a0A.\u00a0Eichenauer, G.\u00a0Lachmann und P.\u00a0La Ros\u00e9e geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}